Somatic hypermutation involving promoter and coding regions of BCL2 is seen in about 35% of DLBCL cases, with the majority being in the GCB subtype (Schuetz et al., 2012). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.